InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,267.84
(
-0.74%
)
US TECH 100
18,150.00
(
-0.43%
)
Dow Jones
39,065.26
(
-1.53%
)
Brent Oil
81.16
(
-0.18%
)
Bitcoin
67,642.07
(
-0.41%
)
Post# of 251927
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

pollyvonwog

Send PM Follow Ignore
Followers 21
Posts 2057
Boards Moderated 0
Alias Born 06/14/2007

pollyvonwog

Re: None

Thursday, 07/29/2010 1:28:27 PM

Thursday, July 29, 2010 1:28:27 PM

Post# of 251927
SNY/MNTA from yahoo boards FWIW:

July 28, 2010
Enoxaparin award
Effective July 27 2010, Premier is pleased to announce the sole award of enoxaparin sodium (Lovenox) to Sanofi-Aventis. Sanofi-Aventis has provided Premier aggressive pricing as well as market leading Auto-sub and DSH pricing.

Premier current estimated annual spend on brand Lovenox is more than $325 million.
The new Sanofi-Aventis agreement for Lovenox will provide Premier members an estimated annual savings over the current base price of up to 40 percent, translating to approximately $46.3 million. How does this effect us when Premier and Novation are the two biggest hospital suppliers.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up